Repare Therapeutics Inc.

NASDAQ: RPTX · Real-Time Price · USD
1.39
0.00 (0.36%)
At close: May 29, 2025, 3:59 PM
1.40
0.72%
After-hours: May 29, 2025, 06:18 PM EDT

Revenue by Geography

Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022
Switzerland Revenue 50.89M 26.1M 15.2M
Switzerland Revenue Growth +94.97% +71.71% n/a
United States Revenue 2.59M 14.5M 116.6M
United States Revenue Growth -82.14% -87.56% n/a

Operating Expense Breakdown

Period Ending Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020 Dec 31, 2019 Sep 30, 2019 Jun 30, 2019 Mar 31, 2019
Selling, General, and Administrative Revenue 7.65M 6.3M 6.44M 8.32M 8.62M 8.53M 7.87M 8.72M 8.53M 7.94M 7.9M 7.94M 8.78M 7.64M 6.6M 6.74M 5.24M 4.79M 4M 3.37M 2.18M 2.02M 1.25M 1.03M 1.08M
Selling, General, and Administrative Revenue Growth +21.44% -2.22% -22.52% -3.49% +1.01% +8.44% -9.76% +2.23% +7.43% +0.44% -0.43% -9.58% +14.92% +15.81% -2.15% +28.72% +9.29% +19.92% +18.51% +54.47% +7.86% +61.92% +21.12% -4.09% n/a
Research and Development Revenue 20.27M 25.74M 28.4M 29.33M 32.47M 34.46M 32.71M 33.79M 31.83M 29.89M 31.24M 31.48M 26.46M 27.97M 25.36M 20.2M 16.51M 12.42M 10.09M 8.95M 8.63M 6.82M 5.62M 4.85M 3.7M
Research and Development Revenue Growth -21.26% -9.36% -3.16% -9.68% -5.78% +5.35% -3.19% +6.15% +6.49% -4.32% -0.74% +18.96% -5.41% +10.30% +25.52% +22.39% +32.95% +23.05% +12.74% +3.70% +26.55% +21.41% +15.76% +31.06% n/a